AI | pharmaphorum

AI

Digital

AI's promise, biotech's peril: How unequal access to computi...

Many biotechs remain locked out of the AI revolution by a combination of cost, complexity, and lack of access to state-of-the-art infrastructure.

Digital

Clinical trials at the core: Decentralised, AI targeted, ESG...

For Inventus' Steve Sanghera and Jim Michel 2025 was a year of progress in clinical trial enablement.

Digital

Healthcare Predictions for the UK in 2026

Digital systems are steadily replacing legacy software and automation tools roll out at speed to cut back the time clinicians spend on manual tasks.

Digital

pharmaphorum podcast Episode 236, Tarek Samad, Lundbeck

An AI supercomputer and discovering next-gen brain disorder ...

Tarek Samad, Lundbeck’s senior vice president and head of research, discusses AI – specifically, Lundbeck’s agreement with the DCAI to operate Gefion.

Patients

The humans the algorithms can't reach

Patients don’t start, stay on, or return to therapy because they receive a notification at the right time.

Sales & Marketing

Doctors and medical affairs round a table in discussion

Breaking tradition to reimagine medical affairs workflows fo...

To stay relevant, medical affairs teams must adapt how they work to meet new demands with greater agility and efficiency.

AI's promise, biotech's peril: How unequal access to computi...

Clinical trials at the core: Decentralised, AI targeted, ESG...

Healthcare Predictions for the UK in 2026

An AI supercomputer and discovering next-gen brain disorder ...

The humans the algorithms can't reach

Breaking tradition to reimagine medical affairs workflows fo...

Allogeneic cell therapy isn’t dead, with Brian Culley

How to meet your physicians where they are online

AI

Editor's Picks